503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Helps investors judge whether earnings growth is driven by sustainable operations or temporary factors. Consistent, organic income expansion can justify a higher intrinsic value for patient, long-term investors.
-11.55%
Revenue decline while ORCL shows 1.12% growth. Joel Greenblatt would examine competitive position erosion.
-9.98%
Cost reduction while ORCL shows 1.56% growth. Joel Greenblatt would examine competitive advantage.
-11.76%
Gross profit decline while ORCL shows 0.85% growth. Joel Greenblatt would examine competitive position.
-0.24%
Both companies show margin pressure. Martin Whitman would check industry conditions.
-8.40%
R&D reduction while ORCL shows 4.54% growth. Joel Greenblatt would examine competitive risk.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-1.09%
Both companies reducing operating expenses. Martin Whitman would check industry trends.
-3.31%
Both companies reducing total costs. Martin Whitman would check industry trends.
No Data
No Data available this quarter, please select a different quarter.
-10.73%
D&A reduction while ORCL shows 11.83% growth. Joel Greenblatt would examine efficiency.
-18.39%
EBITDA decline while ORCL shows 7.46% growth. Joel Greenblatt would examine position.
-28.09%
EBITDA margin decline while ORCL shows 4.74% growth. Joel Greenblatt would examine position.
-18.88%
Operating income decline while ORCL shows 6.44% growth. Joel Greenblatt would examine position.
-8.29%
Operating margin decline while ORCL shows 5.27% growth. Joel Greenblatt would examine position.
138.08%
Other expenses growth above 1.5x ORCL's 31.42%. Michael Burry would check for concerning trends.
-3.34%
Pre-tax income decline while ORCL shows 8.18% growth. Joel Greenblatt would examine position.
9.28%
Pre-tax margin growth 1.25-1.5x ORCL's 6.99%. Bruce Berkowitz would examine sustainability.
-3.37%
Tax expense reduction while ORCL shows 10.56% growth. Joel Greenblatt would examine advantage.
-3.33%
Net income decline while ORCL shows 7.00% growth. Joel Greenblatt would examine position.
9.29%
Net margin growth exceeding 1.5x ORCL's 5.82%. David Dodd would verify competitive advantages.
-5.00%
EPS decline while ORCL shows 0.00% growth. Joel Greenblatt would examine position.
No Data
No Data available this quarter, please select a different quarter.
1.14%
Share count increase while ORCL reduces shares. John Neff would investigate differences.
0.42%
Diluted share reduction exceeding 1.5x ORCL's 1.39%. David Dodd would verify capital allocation.